These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33467114)

  • 1. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.
    Murayama K; Okada M; Tanaka K; Inadomi C; Yoshioka W; Kubotsu Y; Yada T; Isoda H; Kuwashiro T; Oeda S; Akiyama T; Oza N; Hyogo H; Ono M; Kawaguchi T; Torimura T; Anzai K; Eguchi Y; Takahashi H
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33467114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children.
    Shi M; Liu P; Li J; Su Y; Zhou X; Wu C; Chen X; Zheng C
    J Diabetes; 2021 Sep; 13(9):744-753. PubMed ID: 33576570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting.
    Jung TY; Kim MS; Hong HP; Kang KA; Jun DW
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
    Chen J; Mao X; Deng M; Luo G
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
    Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
    BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.
    Zhu J; He M; Zhang Y; Li T; Liu Y; Xu Z; Chen W
    Endocr J; 2018 Mar; 65(3):373-381. PubMed ID: 29434074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.
    Busca C; Sánchez-Conde M; Rico M; Rosas M; Valencia E; Moreno A; Moreno V; Martín-Carbonero L; Moreno S; Pérez-Valero I; Bernardino JI; Arribas JR; González J; Olveira A; Castillo P; Abadía M; Guerra L; Mendez C; Montes ML
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac279. PubMed ID: 35873289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population.
    Cho EJ; Jung GC; Kwak MS; Yang JI; Yim JY; Yu SJ; Chung GE
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK
    Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study.
    Foschi FG; Conti F; Domenicali M; Giacomoni P; Borghi A; Bevilacqua V; Napoli L; Berardinelli D; Altini M; Cucchetti A; Ercolani G; Casadei-Gardini A; Bellentani S; Gastaldelli A; Tiribelli C; Bedogni G; Group BS
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
    Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
    World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of fatty liver prediction scores for diagnosis of fatty liver by Fibroscan.
    Jeong S; Park SJ; Na SK; Park SM; Song BC; Oh YH
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):353-360. PubMed ID: 36870896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents.
    Wan F; Pan F; Ayonrinde OT; Adams LA; Mori TA; Beilin LJ; O'Sullivan TA; Olynyk JK; Oddy WH
    Dig Liver Dis; 2021 Jun; 53(6):746-752. PubMed ID: 33334704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women.
    Fu CP; Ali H; Rachakonda VP; Oczypok EA; DeLany JP; Kershaw EE
    PLoS One; 2019; 14(11):e0224942. PubMed ID: 31770380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.